A new study reveals how brain inflammation from infections and neurodegenerative diseases causes muscle weakness by releasing the IL-6 protein. Researchers found that IL-6 travels from the brain to muscles, reducing their energy production and function. This discovery could lead to treatments for muscle wasting in diseases like Alzheimer's and long COVID. Blocking the IL-6 pathway may prevent muscle weakness associated with brain inflammation.
